Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGENDA: Escitalopram Effects on Depression Endo-Phenotypes in Healthy Relatives
NCT00386841Phase 4Completed
- Sponsor
- University of Copenhagen
- Start
- Apr 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Escitalopram with Placebo (2 arms). Primary endpoint: Response on the combined dexamethasone corticotropin-releasing hormone test. Started Apr 2007; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00386841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00386841.